Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine

Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine

Background: The aim of the present study was to assess the migraine outcome, in particular migraine disability, in chronic (CM) and high frequency episodic migraine (HFEM) patients in treatment with galcanezumab. Methods: The present study was conducted at the Headache Centre of Spedali Civili of Br...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesca Schiano di Cola (Author), Marco Bolchini (Author), Salvatore Caratozzolo (Author), Giulia Ceccardi (Author), Matteo Cortinovis (Author), Paolo Liberini (Author), Renata Rao (Author), Alessandro Padovani (Author)
Format: Book
Published: MDPI AG, 2023-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items